Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD
Public ClinicalTrials.gov record NCT04786990. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV, Open-Label, Flexible-Dose Safety Trial Evaluating SPN-812 Administered With Psychostimulants in Children and Adolescents (6 to 17 Years of Age) With Attention-Deficit/Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This open label, flexible-dose study evaluating the safety and efficacy of SPN-812 administered with psychostimulants in children and adolescents (6 to 17 years of age) with Attention-Deficit/Hyperactivity Disorder (ADHD).
Study identification
- NCT ID
- NCT04786990
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 96 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2021 (Actual)
- Primary completion
- May 23, 2023 (Actual)
- Completion
- Jul 26, 2023 (Actual)
- Last update posted
- May 1, 2024
2021 – 2023
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Preferred Research Partners, Inc. | Little Rock | Arkansas | 72211 | — |
| NRC Research Institute | Orange | California | 92868 | — |
| Miami Clinical Research | Miami | Florida | 33155 | — |
| APG Research, LLC | Orlando | Florida | 32803 | — |
| Elite Clinical Trials | Blackfoot | Idaho | 83221 | — |
| Elite Clinical Trials | Rexburg | Idaho | 83440 | — |
| Qualmedica Research, LLC | Evansville | Indiana | 47715 | — |
| Psychiatric Associates Purehealth Medical Center | Overland Park | Kansas | 66221 | — |
| Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| Alivation Research, LLC | Lincoln | Nebraska | 68526 | — |
| Center for Psychiatry and Behavioral Medicine | Las Vegas | Nevada | 89128 | — |
| SP Research, PLLC | Oklahoma City | Oklahoma | 73112 | — |
| Coastal Carolina Research Center | North Charleston | South Carolina | 29405 | — |
| Gadolin Research, LLC | Beaumont | Texas | 77702 | — |
| Family Psychiatry of The Woodlands | The Woodlands | Texas | 77381 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04786990, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 1, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04786990 live on ClinicalTrials.gov.